Cargando…
Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury
OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the r...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757663/ https://www.ncbi.nlm.nih.gov/pubmed/35106293 http://dx.doi.org/10.5455/javar.2021.h544 |
_version_ | 1784632724983644160 |
---|---|
author | Nipun, Tanzina Sharmin Ema, Tanzila Ismail Mia, Md. Abdur Rashid Hossen, Md. Saddam Arshe, Farzana Alam Ahmed, Shahlaa Zernaz Masud, Afsana Taheya, Fatiha Faheem Khan, Arysha Alif Haque, Fauzia Azad, Salauddin Al Al Hasibuzzaman, Md. Tanbir, Mohammad Anis, Samin Akter, Sharmin Mily, Sabrina Jahan Dey, Dipta |
author_facet | Nipun, Tanzina Sharmin Ema, Tanzila Ismail Mia, Md. Abdur Rashid Hossen, Md. Saddam Arshe, Farzana Alam Ahmed, Shahlaa Zernaz Masud, Afsana Taheya, Fatiha Faheem Khan, Arysha Alif Haque, Fauzia Azad, Salauddin Al Al Hasibuzzaman, Md. Tanbir, Mohammad Anis, Samin Akter, Sharmin Mily, Sabrina Jahan Dey, Dipta |
author_sort | Nipun, Tanzina Sharmin |
collection | PubMed |
description | OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the receptor’s active site properties and quantum tunneling. MATERIALS AND METHODS: A library of 120 phytochemical ligands was prepared, from which 5 were selected considering their absorption, distribution, metabolism, and excretion (ADMET) and quantitative structure–activity relationship (QSAR) profiles. The protein active sites and belonging quantum tunnels were defined to conduct supramolecular docking of the aforementioned ligands. The hydrogen bond formation and hydrophobic interactions between the ligand–receptor complexes were studied following the molecular docking steps. A comprehensive molecular dynamic simulation (MDS) was conducted for each of the ligand–receptor complexes to figure out the values – root mean square deviation (RMSD) (Å), root mean square fluctuation (RMSF) (Å), H-bonds, Cα, solvent accessible surface area (SASA) (Å(2)), molecular surface area (MolSA) (Å(2)), Rg (nm), and polar surface area (PSA) (Å). Finally, computational programming and algorithms were used to interpret the dynamic simulation outputs into their graphical quantitative forms. RESULTS: ADMET and QSAR profiles revealed that the most active candidates from the library to be used were apigenin, isovitexin, piperolactam A, and quercetin as test ligands, whereas serpentine as the control. Based on the binding affinities of supramolecular docking and the parameters of molecular dynamic simulation, the strength of the test ligands can be classified as isovitexin > quercetin > piperolactam A > apigenin when complexed with the hACE2 receptor. Surprisingly, serpentine showed lower affinity (−8.6 kcal/mol) than that of isovitexin (−9.9 kcal/mol) and quercetin (−8.9 kcal/mol). The MDS analysis revealed all ligands except isovitexin having a value lower than 2.5 Ǻ. All the test ligands exhibited acceptable fluctuation ranges of RMSD (Å), RMSF (Å), H-bonds, Cα, SASA (Å(2)), MolSA (Å(2)), Rg (nm), and PSA (Å) values. CONCLUSION: Considering each of the parameters of molecular optimization, docking, and dynamic simulation interventions, all of the test ligands can be suggested as potential targeted drugs in blocking the hACE2 receptor. |
format | Online Article Text |
id | pubmed-8757663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) |
record_format | MEDLINE/PubMed |
spelling | pubmed-87576632022-01-31 Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury Nipun, Tanzina Sharmin Ema, Tanzila Ismail Mia, Md. Abdur Rashid Hossen, Md. Saddam Arshe, Farzana Alam Ahmed, Shahlaa Zernaz Masud, Afsana Taheya, Fatiha Faheem Khan, Arysha Alif Haque, Fauzia Azad, Salauddin Al Al Hasibuzzaman, Md. Tanbir, Mohammad Anis, Samin Akter, Sharmin Mily, Sabrina Jahan Dey, Dipta J Adv Vet Anim Res Original Article OBJECTIVE: This research aims to study the target specificity of selective bioactive compounds in complexing with the human angiotensin-converting enzyme (hACE2) receptor to impede the severe acute respiratory syndrome coronavirus 2 influx mechanism resulting in cardiac injury and depending on the receptor’s active site properties and quantum tunneling. MATERIALS AND METHODS: A library of 120 phytochemical ligands was prepared, from which 5 were selected considering their absorption, distribution, metabolism, and excretion (ADMET) and quantitative structure–activity relationship (QSAR) profiles. The protein active sites and belonging quantum tunnels were defined to conduct supramolecular docking of the aforementioned ligands. The hydrogen bond formation and hydrophobic interactions between the ligand–receptor complexes were studied following the molecular docking steps. A comprehensive molecular dynamic simulation (MDS) was conducted for each of the ligand–receptor complexes to figure out the values – root mean square deviation (RMSD) (Å), root mean square fluctuation (RMSF) (Å), H-bonds, Cα, solvent accessible surface area (SASA) (Å(2)), molecular surface area (MolSA) (Å(2)), Rg (nm), and polar surface area (PSA) (Å). Finally, computational programming and algorithms were used to interpret the dynamic simulation outputs into their graphical quantitative forms. RESULTS: ADMET and QSAR profiles revealed that the most active candidates from the library to be used were apigenin, isovitexin, piperolactam A, and quercetin as test ligands, whereas serpentine as the control. Based on the binding affinities of supramolecular docking and the parameters of molecular dynamic simulation, the strength of the test ligands can be classified as isovitexin > quercetin > piperolactam A > apigenin when complexed with the hACE2 receptor. Surprisingly, serpentine showed lower affinity (−8.6 kcal/mol) than that of isovitexin (−9.9 kcal/mol) and quercetin (−8.9 kcal/mol). The MDS analysis revealed all ligands except isovitexin having a value lower than 2.5 Ǻ. All the test ligands exhibited acceptable fluctuation ranges of RMSD (Å), RMSF (Å), H-bonds, Cα, SASA (Å(2)), MolSA (Å(2)), Rg (nm), and PSA (Å) values. CONCLUSION: Considering each of the parameters of molecular optimization, docking, and dynamic simulation interventions, all of the test ligands can be suggested as potential targeted drugs in blocking the hACE2 receptor. A periodical of the Network for the Veterinarians of Bangladesh (BDvetNET) 2021-09-29 /pmc/articles/PMC8757663/ /pubmed/35106293 http://dx.doi.org/10.5455/javar.2021.h544 Text en Copyright: © Journal of Advanced Veterinary and Animal Research https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ) |
spellingShingle | Original Article Nipun, Tanzina Sharmin Ema, Tanzila Ismail Mia, Md. Abdur Rashid Hossen, Md. Saddam Arshe, Farzana Alam Ahmed, Shahlaa Zernaz Masud, Afsana Taheya, Fatiha Faheem Khan, Arysha Alif Haque, Fauzia Azad, Salauddin Al Al Hasibuzzaman, Md. Tanbir, Mohammad Anis, Samin Akter, Sharmin Mily, Sabrina Jahan Dey, Dipta Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury |
title | Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury |
title_full | Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury |
title_fullStr | Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury |
title_full_unstemmed | Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury |
title_short | Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury |
title_sort | active site-specific quantum tunneling of hace2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing sars-cov-2 influx and subsequent cardiac injury |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757663/ https://www.ncbi.nlm.nih.gov/pubmed/35106293 http://dx.doi.org/10.5455/javar.2021.h544 |
work_keys_str_mv | AT nipuntanzinasharmin activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT ematanzilaismail activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT miamdabdurrashid activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT hossenmdsaddam activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT arshefarzanaalam activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT ahmedshahlaazernaz activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT masudafsana activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT taheyafatihafaheem activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT khanaryshaalif activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT haquefauzia activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT azadsalauddinal activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT alhasibuzzamanmd activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT tanbirmohammad activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT anissamin activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT aktersharmin activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT milysabrinajahan activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury AT deydipta activesitespecificquantumtunnelingofhace2receptortoassessitscomplexingposeswithselectivebioactivecompoundsincosuppressingsarscov2influxandsubsequentcardiacinjury |